Literature DB >> 21289254

Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women.

Judith Aron-Wisnewsky1, Zélie Julia, Christine Poitou, Jean-Luc Bouillot, Arnaud Basdevant, M John Chapman, Karine Clement, Maryse Guerin.   

Abstract

AIM: We tested the hypothesis that quantitative changes in high-density lipoprotein (HDL) particles weight loss induced by Roux-en-Y bypass (RYGBP) in morbidly obese subjects might be associated with improved functionality of these particles in the reverse cholesterol transport pathway. METHODS AND
RESULTS: Thirty-four morbidly obese women were recruited and followed up before and 6 months after RYGBP. After surgery, along with a major weight loss (-20%; P < 0.0001), we observed a significant increase in HDL mass concentration (+14%; P < 0.04), reflecting a specific increase in large HDL2 subfraction levels (+42%; P < 0.01), whereas those of HDL3 remained unchanged. Cholesterol ester transfer protein activity decreased significantly (-15%; P < 0.0001). Efflux capacity of total plasma increased significantly via both scavenger receptor class B type I (SR-BI) (+58%; P < 0.0001) and ATP binding cassette G1 (ABCG1) (+26%; P < 0.0001) pathways. Such enhanced capacity resulted from increased capacity of HDL2 particles to mediate cholesterol efflux through the SR-BI pathway (+56%, P < 0.001) and from the increase plasma level of cholesteryl ester-rich HDL2 particles for the ABCG1 pathway.
CONCLUSION: RYGBP-induced weight loss results in improvement in atherogenic lipid profile including a shift toward a more cardioprotective HDL subfraction profile. In addition, our in vitro studies demonstrated an increased in plasma efflux capacity via both SR-BI and ABCG1 after surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289254     DOI: 10.1210/jc.2010-2378

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

Review 1.  Genetics of cholesterol efflux.

Authors:  Iulia Iatan; Aurélien Palmyre; Sarah Alrasheed; Isabelle Ruel; Jacques Genest
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

2.  Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome.

Authors:  Catherine J Andersen; Christopher N Blesso; Jiyoung Lee; Jacqueline Barona; Dharika Shah; Michael J Thomas; Maria Luz Fernandez
Journal:  Lipids       Date:  2013-03-15       Impact factor: 1.880

3.  Deficiency of FcϵR1 Increases Body Weight Gain but Improves Glucose Tolerance in Diet-Induced Obese Mice.

Authors:  Yun-Jung Lee; Conglin Liu; Mengyang Liao; Galina K Sukhova; Jun Shirakawa; Meriem Abdennour; Karine Iamarene; Sebastien Andre; Karen Inouye; Karine Clement; Rohit N Kulkarni; Alexander S Banks; Peter Libby; Guo-Ping Shi
Journal:  Endocrinology       Date:  2015-08-21       Impact factor: 4.736

Review 4.  Role of HDL in those with diabetes.

Authors:  Carlos G Santos-Gallego; Robert S Rosenson
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

5.  Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.

Authors:  Sean P Heffron; Bing-Xue Lin; Manish Parikh; Bianca Scolaro; Steven J Adelman; Heidi L Collins; Jeffrey S Berger; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

Review 6.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 7.  Treatment of Obesity in Mitigating Metabolic Risk.

Authors:  Sean P Heffron; Johnathon S Parham; Jay Pendse; José O Alemán
Journal:  Circ Res       Date:  2020-05-21       Impact factor: 17.367

Review 8.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

Review 9.  Dysfunctional HDL and atherosclerotic cardiovascular disease.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin J Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Nat Rev Cardiol       Date:  2015-09-01       Impact factor: 32.419

Review 10.  Medical and Surgical Obesity Treatments and Atherosclerosis: Mechanisms beyond Typical Risk Factors.

Authors:  John A Bostrom; Beth Mottel; Sean P Heffron
Journal:  Curr Atheroscler Rep       Date:  2021-08-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.